COMBINATION CHEMOTHERAPY WITH VINCRISTINE SULFATE (VCR), CYCLOPHOSPHAMIDE (CTX), AND ACTINOMYCIN-D (ACT-D) IN CHILDREN WITH MALIGNANT OVARIAN TUMORS

被引：0
|
作者：
CANGIR, A [1 ]
SMITH, J [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1977年 / 18卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [31] VINCRISTINE (VCR) AND ACTINOMYCIN-D (AMD) FOR RECURRENT AND PRIMARY LOW-GRADE CHIASMATIC OPTIC GLIOMAS (COG)
    ROSENSTOCK, JG
    NORRIS, D
    BRUCE, D
    BRUNO, L
    NELSON, D
    BILANIUK, L
    ZIMMERMAN, R
    PACKER, R
    SCHATZ, N
    SAVINO, P
    RORKE, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 405 - 405
  • [32] Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
    Arndt, Carola A. S.
    Stoner, Julie A.
    Hawkins, Douglas S.
    Rodeberg, David A.
    Hayes-Jordan, Andrea A.
    Paidas, Charles N.
    Parham, David M.
    Teot, Lisa A.
    Wharam, Moody D.
    Breneman, John C.
    Donaldson, Sarah S.
    Anderson, James R.
    Meyer, William H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5182 - 5188
  • [33] Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy
    Yuki Kojima
    Kenji Hashimoto
    Masashi Ando
    Kan Yonemori
    Akihiro Hirakawa
    Makoto Kodaira
    Mayu Yunokawa
    Chikako Shimizu
    Kenji Tamura
    Noriyuki Katsumata
    Ako Hosono
    Atsushi Makimoto
    Yasuhiro Fujiwara
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1249 - 1257
  • [34] Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy
    Kojima, Yuki
    Hashimoto, Kenji
    Ando, Masashi
    Yonemori, Kan
    Hirakawa, Akihiro
    Kodaira, Makoto
    Yunokawa, Mayu
    Shimizu, Chikako
    Tamura, Kenji
    Katsumata, Noriyuki
    Hosono, Ako
    Makimoto, Atsushi
    Fujiwara, Yasuhiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (07) : 1249 - 1257
  • [35] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, VINCRISTINE, PROCARBAZINE, AND PREDNISONE (COPP) IN CHILDREN WITH BRAIN-TUMORS
    ETTINGER, LJ
    SINNIAH, D
    SIEGEL, SE
    FISHMAN, LS
    SEGALL, HD
    SONI, D
    BENNETTS, GA
    SCHULTZ, DH
    RAPHAEL, D
    JOURNAL OF NEURO-ONCOLOGY, 1985, 3 (03) : 263 - 269
  • [36] ETOPOSIDE, METHOTREXATE, ACTINOMYCIN-D, CYCLOPHOSPHAMIDE, AND VINCRISTINE FOR THE TREATMENT OF METASTATIC, HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE
    SCHINK, JC
    SINGH, DK
    RADEMAKER, AW
    MILLER, DS
    LURAIN, JR
    OBSTETRICS AND GYNECOLOGY, 1992, 80 (05): : 817 - 820
  • [37] RESULTS WITH THE EMA/CO (ETOPOSIDE, METHOTREXATE, ACTINOMYCIN-D, CYCLOPHOSPHAMIDE, VINCRISTINE) REGIMEN IN HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS, 1979 TO 1989
    NEWLANDS, ES
    BAGSHAWE, KD
    BEGENT, RHJ
    RUSTIN, GJS
    HOLDEN, L
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1991, 98 (06): : 550 - 557
  • [38] MULTIPLE GENOTYPIC CHANGES IN MULTIDRUG-RESISTANT CELLS SELECTED FOR RESISTANCE TO VINCRISTINE (VCR), ACTINOMYCIN-D (AD), OR DAUNORUBICIN (DM)
    MEYERS, MB
    CHANG, TD
    SPENGLER, BA
    BIEDLER, JL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 336 - 336
  • [39] TREATMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE WITH METHOTREXATE, ACTINOMYCIN-D, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
    LURAIN, JR
    BREWER, JI
    OBSTETRICS AND GYNECOLOGY, 1985, 65 (06): : 830 - 836
  • [40] CHEMOTHERAPY COMBINATION WITH CYCLOPHOSPHAMIDE (CTX) ADRIAMYCIN (ADM), VINCRISTINE (VCR), AND VP16-213 IN SMALL CELL-CARCINOMA OF THE LUNG (SCCL)
    GRACIA, JM
    JIMENEZ, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 199 - 201
12345